Clinical Trial

Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 22, 2025 (before its estimated April 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
Population aging has become a significant global concern, and Taiwan is set to officially enter the "super-aged society" in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process. This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatty acid supplementation on middle-aged and elderly individuals (aged 50 and above) who are at high risk for sarcopenia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-27; most recent amendment 2025-06-19.
Trial Details
NCT Number NCT06991855
Lead Sponsor Chang Gung Memorial Hospital
Collaborators: Chang Gung University
Conditions Sarcopenia, Sarcopenia in Elderly
Enrollment 90 participants
Start Date 2025-07-01
Primary Completion 2026-04-10 (estimated)
Study Completion 2026-04-17 (estimated)
Updated on ClinicalTrials.gov 2025-06-22